IT House reported on December 3 that according to a latest study published in the journal "Advanced Science" on November 30, scientists have developed a new type of "miniature human cell robot." Made from human cells, this "human cell robot" could one day detect cancer, repair da

news 2555℃

IT House reported on December 3 that according to a latest study published in the journal "Advanced Science" on November 30, scientists have developed a new type of "miniature human cell robot." Made from human cells, this "human cell robot" could one day detect cancer, repair damaged tissue, and even remove plaque from blood vessels.

IT House reported on December 3 that according to a latest study published in the journal 'Advanced Science' on November 30, scientists have developed a new type of 'miniature human cell robot.' Made from human cells, this 'human cell robot' could one day detect cancer, repair da - Lujuba

Research teams from Tufts University and Harvard University in the United States have successfully developed this "miniature human cell robot" with a diameter of 30 to 500 microns. These robots are composed entirely of human cells and are grown from a single cell. has a natural lifespan and will generally degrade on its own after a few weeks. It is reported that it survived for 60 days in laboratory conditions.

According to IT House, the research was led by Michael Levine, a developmental biologist at Tufts University who created the first living robot four years ago. Made from embryonic heart and skin cells from African clawed frogs, the robots are capable of crawling and swimming and could be used to remove microplastics or fight cancer cells. On this basis, Levine's graduate student Gizem Gumskaya created a new generation of robots using adult tracheal cells. The cilia of the tracheal cells act as tiny paddles to help the robot move.

At present, this research is still in its early stages, but it has shown potential in the medical field. The researchers found that these robots promote the growth of damaged nerve cells, although it's not yet clear why. The research was funded in part by Astonishing Labs, a biotech company working on using this technology to treat neurological diseases and neurospinal injuries.

Tags: news